Literature DB >> 23870812

Treatment of age-related macular degeneration.

Chui Ming Gemmy Cheung1, Tien Y Wong.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23870812     DOI: 10.1016/S0140-6736(13)61580-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Identification of age-related macular degeneration related genes by applying shortest path algorithm in protein-protein interaction network.

Authors:  Jian Zhang; Min Jiang; Fei Yuan; Kai-Yan Feng; Yu-Dong Cai; Xun Xu; Lei Chen
Journal:  Biomed Res Int       Date:  2013-12-18       Impact factor: 3.411

2.  Systemic adverse events after intravitreal bevacizumab versus ranibizumab for age-related macular degeneration: a meta-analysis.

Authors:  Wei Wang; Xiulan Zhang
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

Review 3.  Nutritional and Lifestyle Interventions for Age-Related Macular Degeneration: A Review.

Authors:  Ângela Carneiro; José Paulo Andrade
Journal:  Oxid Med Cell Longev       Date:  2017-01-05       Impact factor: 6.543

4.  EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT AND RANIBIZUMAB IN ASIAN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Subgroup Analyses From the VIEW Trials.

Authors:  Tien Yin Wong; Chui Ming Gemmy Cheung; Timothy Y Y Lai; Shih-Jen Chen; Won Ki Lee; Young Hee Yoon; Tomohiro Iida; Claudia Tueckmantel; Olaf Sowade; Yuichiro Ogura
Journal:  Retina       Date:  2019-03       Impact factor: 4.256

5.  Pattern of adverse events induced by aflibercept and ranibizumab: A nationwide spontaneous adverse event reporting database, 2007-2016.

Authors:  Dongmun Ha; So-Ra Choi; Yongmin Kwon; Han-Heui Park; Ju-Young Shin
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

6.  Understanding patient preferences in anti-VEGF treatment options for age-related macular degeneration.

Authors:  Semra Ozdemir; Eric Finkelstein; Jia Jia Lee; Issac Horng Khit Too; Kelvin Yi Chong Teo; Anna Chen Sim Tan; Tien Yin Wong; Gemmy Chui Ming Cheung
Journal:  PLoS One       Date:  2022-08-11       Impact factor: 3.752

7.  The influence of delayed treatment due to COVID-19 on patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Xinyu Zhao; Lihui Meng; Mingyue Luo; Weihong Yu; Hanyi Min; Rongping Dai; Adrian Koh; Youxin Chen
Journal:  Ther Adv Chronic Dis       Date:  2021-06-22       Impact factor: 5.091

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.